Workup and Management of Gout
The management of gout should follow a treat-to-target approach with urate-lowering therapy (ULT), starting with allopurinol as first-line therapy, aiming for serum uric acid levels below 6 mg/dL, while treating acute flares with colchicine, NSAIDs, or corticosteroids. 1
Diagnostic Workup
Definitive Diagnosis
- Identification of monosodium urate (MSU) crystals in synovial fluid is the gold standard for definitive diagnosis 1
- If crystal identification is not possible, diagnosis can be supported by:
- Classical clinical features (podagra, tophi, rapid response to colchicine)
- Characteristic imaging findings 1
Laboratory Testing
- Serum uric acid level (hyperuricemia typically >6.8 mg/dL)
- Renal function tests (creatinine, BUN)
- Assessment of cardiovascular risk factors 1
Management of Acute Gout Flares
First-Line Options (choose based on comorbidities)
Low-dose colchicine:
NSAIDs:
- Full anti-inflammatory doses
- Avoid in patients with renal impairment, history of GI bleeding, or cardiovascular disease 1
Corticosteroids:
- Options include oral, intramuscular, or intra-articular administration
- Particularly useful when NSAIDs and colchicine are contraindicated 1
Alternative for Refractory Cases
- IL-1 inhibitors can be considered in patients with contraindications to colchicine, NSAIDs, and corticosteroids 1
Long-Term Management
Indications for Urate-Lowering Therapy (ULT)
ULT should be initiated for patients with:
- Tophaceous gout (strong recommendation) 1
- Radiographic damage due to gout (strong recommendation) 1
- Frequent gout flares (≥2 per year) 1
- Chronic kidney disease 1, 3
- History of urolithiasis 4
First-Line ULT
Allopurinol:
- Start at low dose: 100 mg/day (lower in CKD) 1, 5
- Titrate dose by 100 mg increments every 2-4 weeks 3, 5
- Target serum uric acid <6 mg/dL (<5 mg/dL in severe/tophaceous gout) 1, 3
- Typical maintenance dose: 200-300 mg/day for mild gout; 400-600 mg/day for moderate-severe tophaceous gout 5
- Maximum dose: 800 mg/day 5
- For CKD patients:
- CrCl 10-20 mL/min: 200 mg/day
- CrCl <10 mL/min: ≤100 mg/day 5
Alternative ULT Options (if allopurinol fails or is not tolerated)
Febuxostat:
Uricosurics (probenecid, benzbromarone):
Combination therapy:
- Xanthine oxidase inhibitor plus uricosuric 1
Pegloticase:
- Reserved for refractory tophaceous gout when other ULTs have failed 1
Prophylaxis When Starting ULT
Lifestyle and Dietary Modifications
Recommended Changes
- Weight loss if overweight/obese (aim for 5kg reduction) 3
- Regular exercise (avoid strenuous exercise during flares) 3
- Adequate hydration (>2L water daily) 3
- Increase consumption of low-fat dairy products 3
- Consider vegetable protein as alternative to animal protein 3
- Cherries may help reduce frequency of acute attacks 3
Foods/Beverages to Limit or Avoid
- Red meat (limit to 5-7 servings per week) 3
- Organ meats 3
- Seafood 3, 6
- Alcohol, especially beer 3, 6
- Sugar-sweetened beverages and fruit juices (especially with high-fructose corn syrup) 3, 6
Monitoring and Follow-up
- Regular monitoring of serum uric acid levels until target is achieved 1, 3
- Monitor frequency of gout attacks 1
- Measure tophi size if present 1
- Assess medication adherence at each visit 3
- Evaluate and manage comorbidities (hypertension, diabetes, hyperlipidemia, kidney disease) 1, 3
Special Considerations
Renal Impairment
- Avoid NSAIDs 3
- Adjust colchicine dosing (see above) 2
- Adjust allopurinol dosing based on creatinine clearance 5
- Consider febuxostat or benzbromarone as alternatives 1
Cardiovascular Disease
- Consider replacing diuretics with alternative medications when possible 3
- Consider losartan for hypertension management due to its uricosuric effects 3
- For hyperlipidemia, consider fenofibrate due to its modest uricosuric effects 3